Bibliographic Details
| Title: |
Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion. |
| Authors: |
Pfisterer, M (AUTHOR), Burkart, F (AUTHOR), Jockers, G (AUTHOR), Meyer, B (AUTHOR), Regenass, S (AUTHOR), Burckhardt, D (AUTHOR), Schmitt, H E (AUTHOR), Müller-Brand, J (AUTHOR), Skarvan, K (AUTHOR), Stulz, P (AUTHOR) |
| Source: |
Lancet. 7/1/1989, Vol. 334 Issue 8653, p1-7. 7p. |
| Abstract: |
In a prospective randomised trial, 249 patients who had aortocoronary vein bypass surgery were assigned either to a platelet inhibitory drug regimen or to standard anticoagulant therapy. Treatment was replaced by placebo in half of the patients in each group after 3 months. The platelet inhibitory drug regimen--very low-dose aspirin combined with dipyridamole--was as effective as standard anticoagulant therapy to prevent early and late graft occlusion. Death, myocardial infarction, and severe bleeding occurred significantly more often in patients receiving anticoagulants, whereas mild drug-related gastrointestinal and cerebral side-effects were more common in patients taking platelet inhibitory drugs. Antithrombotic treatment should be continued for at least 1 year after coronary artery bypass graft surgery. [ABSTRACT FROM AUTHOR] |
|
Copyright of Lancet is the property of Lancet and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Psychology and Behavioral Sciences Collection |
